Atara Biotherapeutics Inc. (ATRA) Declined -8.14% or -3.75 To Price $42.3 On Tuesday

Atara Biotherapeutics Inc. (ATRA) declined -8.14% or -3.75 to $42.3. It is close to 365982 shares traded, which is 38.02% compare to the average total volume 962505. The market cap of ATRA is $1.64 billion. The year to date change is 154.42%. The 52 week price range is from $11.8 to $49.9. Price of ATRA have changed 5.98% during last week. It have changed 16.66% over last month, N/A N/A and 102.86% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ATRA is 34.10. It is -19.39% below current price. The 200-day Moving Averages for ATRA is 19.54. It is -53.81% below current price. The 52-week High is 49.9. It is 17.97% from the current price. The 52-week Low is 11.8. It is -72.10% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ATRA is 5.52 on 2018-02-28. Short % to float is 13.55%. There are some statistics of ATRA. It is has market cap $1.64 billion. The share outstanding is 38.83 million. The average volume is 962505. The percent of top 15 Institution holding is 83.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ATRA is -55.37%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ATRA is -49.61%.


Share this post